A translatable predictor of human radiation exposure

Area of Science:

• Radiation biology
• Medical countermeasures
• Public health

Background:

• Radiological and nuclear terrorism poses significant public health and national security threats.
• Effective medical management of radiation disasters requires rapid, high-throughput biodosimetry for mass casualty triage.
• Current biodosimetric methods are insufficient for large-scale radiation injury assessment.

Purpose of the Study:

• To develop a novel, accurate, and high-throughput biodosimetric assay for assessing radiation exposure in humans.
• To identify a reliable gene expression profile for predicting human radiation injury and dose levels.
• To evaluate the potential of a chemical ligation-dependent probe amplification assay (CLPA) for clinical biodosimetry.

Main Methods:

• Analysis of gene expression profiles in irradiated mice, ex vivo human peripheral blood (PB), and human total body irradiation (TBI) patients.
• Development of an 18-gene radiation classifier incorporating human PB and TBI data.
• Incorporation of the human radiation signature into a chemical ligation-dependent probe amplification assay (CLPA).

Main Results:

• A gene expression profile from murine data alone was insufficient for predicting human radiation injury.
• An 18-gene classifier derived from human ex vivo PB and TBI data accurately predicted human radiation status and dose levels.
• The classifier's accuracy was not significantly affected by gender, diagnosis, or prior chemotherapy in TBI patients.
• The CLPA assay successfully discriminated radiation dose levels in ex vivo irradiated human blood and TBI patient samples.

Conclusions:

• A human-specific gene expression signature can accurately diagnose radiation exposure.
• The developed 18-gene classifier shows promise for biodosimetry in radiation emergencies.
• The CLPA assay is a potential candidate for a rapid, high-throughput biodosimetric tool for radiation disaster victims.